This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Sebastian G. Schneeweiss, MD, MSc; Martin Goettler, MD, MPH; Joerg Hasford, MD, PhD
University of Munich Medical School Munich, Germany

JAMA. 1997;277(17):1352-1353.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Dr Bates et al¹ and Dr Classen et al² dem onstrated the significant impact of ADEs on length of stay and costs of hospitalizations. However, the reported economic burden of $4685 for preventable ADEs and $2595 for all ADEs in the article by Bates et al,¹ and $2013 for all ADEs in the work by Classen et al,² only consider adverse drug events that were acquired in hospitals. To put the consequences of ADEs during hospitalization in relation to all ADEs, it is necessary to quantify the burden of adverse events in ambulatory care as well.

We performed a meta-analytic review of 21 original studies published from 1975 through 1996 and identified 13 reports in adults admitted to medical or emergency services because of ADEs in 4 industrialized countries or regions (United States 3, Europe 8, South Africa 1, Taiwan 1). The meta-analysis used the World . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?